Abstract
We report on P2X7 receptor antagonists based on a lead adamantly-cyanoguanidine-aryl moiety. We have investigated the importance of the central cyanoguanidine moiety by replacing it with urea, thiourea or guanidine moieties. We have also investigated the linker length between the central moiety and the aryl portion. All compounds were assessed for their inhibitory potency in a pore-formation dye uptake assay at the P2X7 receptor. None of the compounds resulted in an improved potency illustrating the importance of the cyanoguanidine moiety in this chemotype.
Keywords:
Cyanoguanidine; Inflammation; P2X(7)R; Thiourea; Urea.
Copyright © 2017 Elsevier Ltd. All rights reserved.
Publication types
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Adamantane / analogs & derivatives
-
Adamantane / chemistry
-
Adenosine Triphosphate / analogs & derivatives
-
Adenosine Triphosphate / pharmacology
-
Benzoxazoles / metabolism
-
Cell Line
-
Fluorescent Dyes / metabolism
-
Guanidines / chemistry
-
Guanidines / pharmacology*
-
Humans
-
Molecular Structure
-
Purinergic P2X Receptor Agonists / pharmacology
-
Purinergic P2X Receptor Antagonists / chemistry
-
Purinergic P2X Receptor Antagonists / pharmacology*
-
Quinolinium Compounds / metabolism
-
Thiourea / analogs & derivatives*
-
Thiourea / chemistry
-
Thiourea / pharmacology*
-
Urea / analogs & derivatives*
-
Urea / chemistry
-
Urea / pharmacology*
Substances
-
Benzoxazoles
-
Fluorescent Dyes
-
Guanidines
-
Purinergic P2X Receptor Agonists
-
Purinergic P2X Receptor Antagonists
-
Quinolinium Compounds
-
YO-PRO 1
-
3'-O-(4-benzoyl)benzoyladenosine 5'-triphosphate
-
Adenosine Triphosphate
-
Urea
-
Thiourea
-
Adamantane